Feasibility of a smartphone app to monitor patient reported outcomes in multiple sclerosis: The haMSter interventional trial

BACKGROUND: Monitoring of patient outcomes in multiple sclerosis (MS) is fundamental for individualized treatment decisions. So far, these decisions have been motivated by conventional outcomes, i.e., relapses or clinical disability supported by radiological disease activity. Complementing this conc...

Descripción completa

Detalles Bibliográficos
Autores principales: Altmann, Patrick, Ponleitner, Markus, Monschein, Tobias, Krajnc, Nik, Zulehner, Gudrun, Zrzavy, Tobias, Leutmezer, Fritz, Rommer, Paulus Stefan, Kornek, Barbara, Berger, Thomas, Bsteh, Gabriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638697/
https://www.ncbi.nlm.nih.gov/pubmed/36353697
http://dx.doi.org/10.1177/20552076221135387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638697/
https://www.ncbi.nlm.nih.gov/pubmed/36353697
http://dx.doi.org/10.1177/20552076221135387

Ejemplares similares